« FDA Approvals - Glenmark's Baddi semi-solids manufacturing facility gets US FDA nod (PharmaBiz) | Main | FDA Approves First Clotting Solution Made Using Recombinant DNA Technology »

Milestone Scientific Names Joseph D'Agostino as Acting Chief Financial Officer


Milestone Scientific Names Joseph D'Agostino as Acting Chief Financial Officer (PR Newswire via Yahoo! Finance)
Milestone Scientific Inc. , the recognized leader in advanced injection technologies, today announced that Joseph D'Agostino, CPA, has been appointed as the Company's new Acting Chief Financial Officer, replacing former Acting CFO, Arthur Goldberg.

ARTEL Streamlines Quality Control For Automated Liquid Handlers With New MVS Feature (PharmaceuticalOnline)
ARTEL has advanced the automation of its MVS Multichannel Verification System for streamlined liquid delivery performance verification of automated liquid handlers. The MVS is a rapid, easy-to-use system that provides NIST-traceable accuracy and precision data documenting the volume dispense performance of each channel of an automated liquid handler.
 

©2006 FDA-News.com. All rights reserved.